Mechanisms of autoantibody-induced pathology RJ Ludwig, K Vanhoorelbeke, F Leypoldt, Z Kaya, K Bieber, ... Frontiers in immunology 8, 603, 2017 | 469 | 2017 |
Myocardial ischemia/reperfusion injury is mediated by leukocytic Toll-like receptor-2 and reduced by systemic administration of a novel anti–Toll-like receptor-2 antibody F Arslan, MB Smeets, LAJ O'Neill, B Keogh, P McGuirk, L Timmers, ... Circulation 121 (1), 80-90, 2010 | 450 | 2010 |
Coxiella burnetii Isolates Cause Genogroup-Specific Virulence in Mouse and Guinea Pig Models of Acute Q Fever KE Russell-Lodrigue, M Andoh, MWJ Poels, HR Shive, BR Weeks, ... Infection and immunity 77 (12), 5640-5650, 2009 | 132 | 2009 |
Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy C Tersteeg, S de Maat, SF De Meyer, MWJ Smeets, AD Barendrecht, ... Circulation 129 (12), 1320-1331, 2014 | 93 | 2014 |
Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura C Tersteeg, A Schiviz, SF De Meyer, B Plaimauer, F Scheiflinger, ... Arteriosclerosis, thrombosis, and vascular biology 35 (11), 2336-2342, 2015 | 86 | 2015 |
N-acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura C Tersteeg, J Roodt, WJ Van Rensburg, C Dekimpe, N Vandeputte, ... Blood, The Journal of the American Society of Hematology 129 (8), 1030-1038, 2017 | 75 | 2017 |
FLow-Induced PRotrusions (FLIPRs) A Platelet-Derived Platform for the Retrieval of Microparticles by Monocytes and Neutrophils C Tersteeg, HF Heijnen, A Eckly, G Pasterkamp, RT Urbanus, C Maas, ... Circulation research 114 (5), 780-791, 2014 | 62 | 2014 |
Clinical pharmacology of caplacizumab for the treatment of patients with acquired thrombotic thrombocytopenic purpura ML Sargentini-Maier, P De Decker, C Tersteeg, J Canvin, F Callewaert, ... Expert Review of Clinical Pharmacology 12 (6), 537-545, 2019 | 61 | 2019 |
Different stages of intraplaque hemorrhage are associated with different plaque phenotypes: a large histopathological study in 794 carotid and 276 femoral endarterectomy specimens WJM Derksen, W Peeters, GW van Lammeren, C Tersteeg, ... Atherosclerosis 218 (2), 369-377, 2011 | 60 | 2011 |
Age and coumarin-type anticoagulation are associated with the occurrence of intraplaque hemorrhage, while statins are associated less with intraplaque hemorrhage: a large … WJM Derksen, W Peeters, C Tersteeg, JPPM de Vries, DPV de Kleijn, ... Atherosclerosis 214 (1), 139-143, 2011 | 54 | 2011 |
A fibronectin‐fibrinogen‐tropoelastin coating reduces smooth muscle cell growth but improves endothelial cell function C Tersteeg, M Roest, EM Mak‐Nienhuis, E Ligtenberg, IE Hoefer, ... Journal of cellular and molecular medicine 16 (9), 2117-2126, 2012 | 41 | 2012 |
Tracking down contact activation–from coagulation in vitro to inflammation in vivo S Maat, C Tersteeg, E Herczenik, C Maas International journal of laboratory hematology 36 (3), 374-381, 2014 | 40 | 2014 |
The role of platelet and endothelial GARP in thrombosis and hemostasis E Vermeersch, F Denorme, W Maes, SF De Meyer, K Vanhoorelbeke, ... PloS one 12 (3), e0173329, 2017 | 37 | 2017 |
Limited Role for Iron Regulation in Coxiella burnetii Pathogenesis HL Briggs, N Pul, R Seshadri, MJ Wilson, C Tersteeg, ... Infection and immunity 76 (5), 2189-2201, 2008 | 34 | 2008 |
Anti-ADAMTS13 antibodies and a novel heterozygous p. R1177Q mutation in a case of pregnancy-onset immune-mediated thrombotic thrombocytopenic purpura E Roose, C Tersteeg, R Demeersseman, AS Schelpe, L Deforche, ... TH Open 2 (01), e8-e15, 2018 | 30 | 2018 |
Generation of anti-murine ADAMTS13 antibodies and their application in a mouse model for acquired thrombotic thrombocytopenic purpura L Deforche, C Tersteeg, E Roose, A Vandenbulcke, N Vandeputte, ... PLoS One 11 (8), e0160388, 2016 | 30 | 2016 |
ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura–current perspectives and new treatment strategies C Tersteeg, S Verhenne, E Roose, AS Schelpe, H Deckmyn, SF De Meyer, ... Expert Review of Hematology 9 (2), 209-221, 2016 | 28 | 2016 |
Keeping von Willebrand factor under control: alternatives for ADAMTS13 C Tersteeg, R Fijnheer, G Pasterkamp, PG de Groot, K Vanhoorelbeke, ... Seminars in thrombosis and hemostasis 42 (01), 009-017, 2016 | 24 | 2016 |
Microlyse: a thrombolytic agent that targets VWF for clearance of microvascular thrombosis S de Maat, CC Clark, AD Barendrecht, S Smits, ND van Kleef, H El Otmani, ... Blood, The Journal of the American Society of Hematology 139 (4), 597-607, 2022 | 23 | 2022 |
Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice C Tersteeg, BS Joly, A Gils, R Lijnen, H Deckmyn, PJ Declerck, ... Journal of Thrombosis and Haemostasis 15 (12), 2432-2442, 2017 | 18 | 2017 |